论文部分内容阅读
目的对舒利迭治疗咳嗽变异性哮喘的影响进行临床分析。方法 80例咳嗽变异性哮喘患者,随机分为对照组和研究组,每组40例,对照组使用常规药物进行治疗,研究组使用常规药物加舒利迭进行治疗,观察比较两组患者的临床治疗效果。结果研究组治疗总有效率92.5%明显高于对照组的77.5%,差异具有统计学意义(P<0.05);两组患者均未出现严重的不良反应。结论使用舒利迭治疗咳嗽变异性哮喘患者的临床效果较好,患者的不良反应少,具有一定的临床使用价值。
Objective To analyze the effect of seretide on cough variant asthma. Methods Eighty patients with cough variant asthma were randomly divided into control group and study group, 40 cases in each group. The control group was treated with conventional drugs. The study group was treated with conventional drug plus seretide. The clinical efficacy of the two groups were compared treatment effect. Results The total effective rate of study group was 92.5%, which was significantly higher than that of the control group (77.5%, P <0.05). No serious adverse reactions occurred in both groups. Conclusions The use of seretide in the treatment of patients with cough variant asthma has a good clinical effect, with fewer side effects and a certain clinical value.